NCT01610635

Brief Summary

It is hypothesised that the number of donations made by English blood donors will be greater with reduced vs. standard inter-donation intervals. The null hypothesis is that there will be no difference in donations between treatment groups; this may arise if reduced inter-donation intervals result in a greater number of donation deferrals (due to low haemoglobin) and/or an unacceptable burden to donors.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

25 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2012

Completed
1 day until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 4, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

June 10, 2015

Status Verified

June 1, 2015

Enrollment Period

4 years

First QC Date

May 31, 2012

Last Update Submit

June 9, 2015

Conditions

Keywords

RCTblood donation frequencyquality of lifeiron deficiency

Outcome Measures

Primary Outcomes (1)

  • Total blood collected after two years

    Expressed in units (470ml) per person per year

    24 months

Secondary Outcomes (7)

  • Donor quality of life

    24 months

  • Number of donation deferrals

    24 months

  • Markers of iron status

    24 months

  • Cognitive ability

    24 months

  • Levels of physical activity

    24 months

  • +2 more secondary outcomes

Study Arms (6)

Male - 8 weeks

EXPERIMENTAL

Male donors assigned to an 8 week donation interval frequency

Other: Reduced versus standard intervals between blood donations

Male - 10 weeks

EXPERIMENTAL

Male donors assigned to 10 week donation interval frequency

Other: Reduced versus standard intervals between blood donations

Male - 12 weeks

NO INTERVENTION

Male donors assigned to 12 week donation interval frequency

Female - 12 weeks

EXPERIMENTAL

Female donors assigned to 12 week donation interval frequency

Other: Reduced versus standard intervals between blood donations

Female - 14 weeks

EXPERIMENTAL

Female donors assigned to 14 week donation interval frequency

Other: Reduced versus standard intervals between blood donations

Female - 16 weeks

NO INTERVENTION

Female donors assigned to 16 week donation interval frequency

Interventions

Over a period of two years participants will be invited to give blood either at usual donation intervals or more frequently. Men will be invited to donate every 12, 10 or 8 weeks and women every 16, 14 or 12 weeks.

Female - 12 weeksFemale - 14 weeksMale - 10 weeksMale - 8 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older and fulfilling all normal criteria for blood donation
  • Willing to be assigned to any of the study intervention groups
  • Registered at one of the permanent donation clinics at the time of enrolment

You may not qualify if:

  • As the aim of the study is to be almost "paper-less", it will involve remote web-based data collection. Hence, participants who do not have internet access and/or are not willing to provide an email address for study correspondence will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (25)

Brentwood Blood Donor Centre

Brentwood, Essex, CM15 8DP, United Kingdom

Location

Edgware Blood Donor Centre

Edgware, Middlesex, HA8 0AD, United Kingdom

Location

Birmingham Blood Donor Centre

Birmingham, B2 4DU, United Kingdom

Location

Bradford Blood Donor Centre

Bradford, BD1 3SH, United Kingdom

Location

Bristol Blood Donor Centre

Bristol, BS10 5ND, United Kingdom

Location

Cambridge Blood Donor Centre

Cambridge, CB2 0PT, United Kingdom

Location

Gloucester Blood Donor Centre

Gloucester, GL1 3HF, United Kingdom

Location

Lancaster Blood Donor Centre

Lancaster, LA1 4GT, United Kingdom

Location

Leeds City Centre Blood Donor Centre

Leeds, LS1 5JX, United Kingdom

Location

Leeds Blood Donor Centre

Leeds, LS15 7TW, United Kingdom

Location

Leicester Blood Donor Centre

Leicester, LE1 4SJ, United Kingdom

Location

Liverpool Blood Donor Centre

Liverpool, L2 2BS, United Kingdom

Location

Tooting Blood Donor Centre

London, SW17 0RB, United Kingdom

Location

West End Blood Donor Centre

London, W1W 8NB, United Kingdom

Location

Luton Blood Donor Centre

Luton, LU1 2NF, United Kingdom

Location

Manchester Plymouth Grove

Manchester, M13 9LL, United Kingdom

Location

Manchester Norfolk House Blood Donor Centre

Manchester, M2 1DW, United Kingdom

Location

Newcastle Blood Donor Centre

Newcastle, NE2 4NQ, United Kingdom

Location

Nottingham Blood Donor Centre

Nottingham, NG7 1FR, United Kingdom

Location

Oxford Blood Donor Centre

Oxford, OX3 9DU, United Kingdom

Location

Plymouth Blood Donor Centre

Plymouth, PL6 8DH, United Kingdom

Location

Poole Blood Donor Centre

Poole, BH15 1SX, United Kingdom

Location

Sheffield Blood Donor Centre

Sheffield, S1 2GN, United Kingdom

Location

Southampton Blood Donor Centre

Southampton, SO16 5AF, United Kingdom

Location

Stoke Blood Donor Centre

Stoke, ST1 4BT, United Kingdom

Location

Related Links

MeSH Terms

Conditions

Iron Deficiencies

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • John Danesh

    University of Cambridge

    PRINCIPAL INVESTIGATOR
  • David Roberts

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Epidemiology and Medicine, Head of Department of Public Health and Primary Care

Study Record Dates

First Submitted

May 31, 2012

First Posted

June 4, 2012

Study Start

June 1, 2012

Primary Completion

June 1, 2016

Study Completion

December 1, 2016

Last Updated

June 10, 2015

Record last verified: 2015-06

Locations